IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
2025 · Biomarker Research · 4 citations
https://doi.org/10.1186/s40364-025-00769-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
284
Citations
5
h-index
4
i10-index
Azadeh Hajmirza is an academic researcher from Institute for Research in Immunology and Cancer. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Protein Degradation and Inhibitors & Advanced biosensing and bioanalysis techniques. The author has an h-index of 5, co-authored 11 publications.
Click to start Chat